UCB Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 162,95 EUR | -0,12% |
|
+1,59% | +106,53% |
| 06/09 | UCB verzorgt presentaties op epilepsiecongres in Rome | AM |
| 26/08 | Sana Biotechnology, Inc. kondigt de benoeming aan van Dhaval Patel als Executive Vice President en Chief Scientific Officer | CI |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet ($) (Y-1) | Nettomarge (Y-1) | Bedrijfsmarge (Y-1) | ROE (Y-1) | ROA (Y-1) | Hefboom (schuld/EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 5,82 mld. | +6.53% | +12.51% | +8.83% | +5.07% | 1.61x | ||
| 14,8 mld. | +17.85% | +25.76% | +15.94% | +7.12% | 2.22x | ||
| 2,78 mld. | +23.21% | +30.14% | +9.12% | +5.26% | -0.16x | ||
| 9,84 mld. | +11.80% | +25.87% | +15.21% | +4.52% | 1.94x | ||
| 2,42 mld. | +6.93% | +6.54% | +3.51% | +2.54% | 0.05x | ||
| 72,68 mln. | -3.49% | -10.09% | -2.44% | -1.34% | 13.25x | ||
| 3,7 mld. | +16.17% | +16.79% | +12.50% | +9.47% | -5.2x | ||
| 777 mln. | +22.64% | +25.43% | +9.97% | +7.81% | -2.15x | ||
| 2,17 mld. | +10.89% | +20.27% | +7.98% | +3.81% | 2.51x | ||
| 875 mln. | -16.56% | -27.06% | -8.84% | -5.38% | 10.88x | ||
| 464 mln. | -30.08% | -34.32% | -22.39% | -18.84% | 3.15x | ||
| 7,31 mld. | +0.90% | +15.52% | +3.72% | +1.04% | 6.42x | ||
| 7,46 mld. | +15.25% | +17.71% | +29.09% | +18.29% | -0.34x | ||
| 1,12 mld. | +22.34% | +27.94% | +6.06% | +5.70% | - | ||
| 730 mln. | +21.42% | +34.84% | +11.93% | +8.19% | - | ||
| 9,3 mln. | -6,913.92% | -6,528.75% | - | -108.65% | -2.18x | ||
| 9,56 mln. | -2,219.87% | -2,464.41% | - | - | - | ||
| 397 mln. | -133.29% | -130.39% | -290.14% | -68.26% | 0.5x | ||
| 271 mln. | -88.41% | -85.67% | -159.21% | - | 0.93x | ||
| 258 mln. | -10.94% | +8.38% | - | - | - | ||
| Gemiddelde | 3,06 mld. | -462,03% | -450,65% | -20,54% | -7,27% | 2,09x | |
| Gewogen gemiddelde per kap. | 6,75 mld. | -121,35% | -113,47% | +3,62% | +2,19% | 1,83x |
- Beurs
- Aandelen
- Koers UCB
- Sector UCB
- Financiële vergelijkingen
